Using donor ILC2 from CD45.1 transgenic mice, we performed immunofluorescent staining and detected the expression of ST2 and ICOS from CD45.1+ donor ILC2 in Rorafl/flIl7rCre/+ recipient mouse AAA lesions (Figure S11A/B, Supporting Information). This evidence concerns the gene ICOS and triple-A syndrome.